On May 21, 2003, GW Pharmaceuticals, makers of Sativex, a cannabis based medicinal inhalant, announced their 40 million dollar marketing partnership with Bayer. Malmo-Levine looks at the history of Bayer and their criminal activities in ...See moreOn May 21, 2003, GW Pharmaceuticals, makers of Sativex, a cannabis based medicinal inhalant, announced their 40 million dollar marketing partnership with Bayer. Malmo-Levine looks at the history of Bayer and their criminal activities in all three world wars. Then DML conducts an interview with Ikechi Mgbeoji, professor of Law at UBC, and his opinion on the viability of a cannabis monopoly though pharmaceutical plant patents of existing strains. Written by
Pot TV
See less